CurrentEndo — Gestational diabetes & diabetes in pregnancy

Clinical readiness of first-trimester gestational diabetes prediction: From risk score to care pathway

2026-11-14T06:45:51.583Z

Research article · Diabetes Res Clin Pract, 2026.

Real‐world evaluation of the NHS testing criteria for glucokinase hyperglycaemia in pregnancy

2026-11-13T22:45:40.907Z

Cohort study · Diabet Med, 2026.

Diabetes Type and Perinatal Adverse Outcomes Among Women in Pregnancy and Neonates in Japan: A Cohort Study Using a Large‐Scale Database

2026-11-13T17:00:16.153Z

Cohort study · Diabetes Obes Metab, 2026.

Maternal insulin resistance and maternal β‐cell function during pregnancy for offspring overweight before 2 years of age among women with gestational diabetes

2026-11-13T10:54:04.269Z

Cohort study · Pediatr Obes, 2022. Offspring overweight — High HOMA-IR: OR 1.71 (95% CI 1.12-2.62); overweight within 12 months of age

Metagenomic characterization of the maternal prenatal gastrointestinal microbiome by pregravid BMI

2026-11-13T10:47:54.884Z

Cross-sectional study · Obesity (Silver Spring), 2022. Gastrointestinal microbiome composition and function — Obesity or overweight vs Normal weight; p = 0.02; decrease in α diversity with obesity or overweight

Racial/ethnic disparities in sleep‐disordered breathing during pregnancy in the nuMoM2b study

2026-11-13T10:47:54.884Z

Secondary analysis · Obesity (Silver Spring), 2023. nHB vs nHW: OR 1.81 (95% CI 1.07, 2.97); SDB prevalence at 6 to 15 weeks

Adjustment of Maternal Variable Rate Insulin Infusions Using Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes

2026-11-13T10:42:28.137Z

Cohort study · Diabetes Technol Ther, 2023. Overall median absolute relative difference (CGM vs point-of-care glucose): Overall median absolute relative difference 6.1 (1.6-17.3)%

Rollout of Closed-Loop Technology to Pregnant Women with Type 1 Diabetes: Healthcare Professionals' Views About Potential Challenges and Solutions

2026-11-13T10:42:28.137Z

Research article · Diabetes Technol Ther, 2023. Healthcare professionals' views on rollout of closed-loop in pregnancy: Enthusiasm for a national rollout of closed-loop, but anticipated challenges, some specific to pregnancy

Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysis

2026-11-13T10:41:04.791Z

Meta-analysis · BMJ Open Diabetes Res Care, 2023. MCM rates — Metformin vs Control: OR 0.93 (95% CI 0.09 to 9.21); p value=0.58; PCOS, RCTs (57 exposed, 52 control infants); I2=0%; Q test=0.31

Does recurrent gestational diabetes mellitus increase the risk of preterm birth? A population-based cohort study

2026-11-13T10:35:20.262Z

Cohort study · Diabetes Res Clin Pract, 2023. Preterm birth (<37 gestational weeks) — GDM vs No GDM: aOR 1.28 (95 % CI 1.14-1.45); nullipara

Miscarriage, stillbirth and the risk of diabetes in women: A systematic review and meta-analysis

2026-11-13T10:35:20.262Z

Meta-analysis · Diabetes Res Clin Pract, 2022. Diabetes risk — Miscarriage vs No miscarriage: OR (non-gestational diabetes) 1.15 (95% CI 1.02-1.28)

Obesity and risk of gestational diabetes mellitus: A two-sample Mendelian randomization study

2026-11-13T10:35:20.262Z

Research article · Diabetes Res Clin Pract, 2023. Odds of GDM per 1-SD increase in obesity trait (univariate MR): Body mass index (BMI): OR 1.64, P = 5.05 × 10-17

Pre-pregnancy body mass index and risk of maternal or infant complications with gestational diabetes mellitus as a mediator: A multicenter, longitudinal cohort study in China

2026-11-13T10:35:20.262Z

Cohort study · Diabetes Res Clin Pract, 2023. Maternal or infant complications by pBMI — Obese vs Normal pBMI: OR (gestational hypertension) 5.38 (95% CI 3.48-8.34)

Prevalence of preeclampsia and uterine arteries resistance in the different phenotypes of gestational diabetes mellitus

2026-11-13T10:35:20.262Z

Cohort study · Diabetes Res Clin Pract, 2022. Prevalence of preeclampsia: AF 17.9% · AP 26.8% · AC 30%

The prospective association of hyperandrogenism, oligomenorrhea and polycystic ovary syndrome with incident gestational diabetes: The coronary artery risk development in young adults women’s study

2026-11-13T10:35:20.262Z

Cohort study · Diabetes Res Clin Pract, 2023. GDM: PCOS associated with elevated risk of GDM 2.6-fold

Trajectory of serum bilirubin in offspring of women with gestational diabetes mellitus

2026-11-13T10:35:20.262Z

Case-control study · Diabetes Res Clin Pract, 2023. Mean percent variation of TSB, birth to 48 h — GDM vs Controls; p = 0.01; significantly higher with GDM

Attendance at pre‐pregnancy care clinics for women with type 1 diabetes: A scoping review

2026-11-13T10:31:52.844Z

Research article · Diabet Med, 2022. Barriers to PPC attendance: Multiple barriers to PPC attendance, many unchanged since the 1990s

First‐trimester glycaemic markers as predictors of gestational diabetes and its associated adverse outcomes: A prospective cohort study

2026-11-13T10:31:52.844Z

Cohort study · Diabet Med, 2022. <14 weeks: GDM 35.7 mmol/mol · Non-GDM 32.9 mmol/mol

Gestational diabetes mellitus in early pregnancy amongst Asian Indian women: Evidence for poor pregnancy outcomes despite treatment

2026-11-13T10:31:52.844Z

Cohort study · Diabet Med, 2022. Pregnancy outcomes vs Non-GDM: E-GDM vs Non-GDM: higher odds of premature birth, large for gestational age (LGA) babies, macrosomia, Neonatal ICU (NICU) admission; lower odds of normal vaginal delivery

Healthcare professionals' views about how pregnant women can benefit from using a closed‐loop system: Qualitative study

2026-11-13T10:31:52.844Z

Research article · Diabet Med, 2023. Themes from HCP interviews: Clinical and quality-of-life benefits of closed-loop in pregnancy, some attributed to the CGM component

Missed antenatal diabetes care appointments and neonatal outcomes for pregnancies with Type 1 and Type 2 diabetes

2026-11-13T10:31:52.844Z

Cohort study · Diabet Med, 2022. Missed appointment vs No missed appointment: aOR 1.95 (95% CI 1.15, 3.31); T1D: caesarean section

Postpartum uptake of diabetes screening tests in women with gestational diabetes: The PANDORA study

2026-11-13T10:31:52.844Z

Cohort study · Diabet Med, 2022. Postpartum screening with an OGTT, 12 weeks and 6 months postpartum: OGTT screening by 12 weeks: Aboriginal and/or Torres Strait Islander vs non-Indigenous 18% vs. 30%

The association between offspring birthweight and future risk of maternal diabetes: A population‐based study

2026-11-13T10:31:52.844Z

Cohort study · Diabet Med, 2022. Incident maternal diabetes — 97th–100th percentile vs 50th–74.9th percentile: aHR 2.30 (95% CI 2.16-2.46); adjusted for maternal age, parity, year, ethnicity, GDM and hypertensive disorders of pregnancy (HDP)

Maternal obesity and gestational diabetes reprogram the methylome of offspring beyond birth by inducing epigenetic signatures in metabolic and developmental pathways

2026-11-13T10:28:29.610Z

Cohort study · Cardiovasc Diabetol, 2023. DNA methylation (>770,000 CpG sites), 0, 6 and 12 months: Abundant DNA methylation changes during development from birth to 6 months and, to a lesser extent, up to 12 months

PNPLA3 rs738409 risk genotype decouples TyG index from HOMA2-IR and intrahepatic lipid content

2026-11-13T10:28:29.610Z

Mechanistic study · Cardiovasc Diabetol, 2023. Correlations of HOMA2-IR, TyG and HTGC: HOMA2-IR vs TyG correlation, CC R = 0.52, p = 0.0054

Impact of iron supplementation on gestational diabetes mellitus: A literature review

2026-11-13T10:20:05.638Z

Research article · Diabetes Obes Metab, 2022. Review of the necessity of iron supplementation and iron homeostasis in pregnancy, the role of iron in beta cells and mechanisms by which excess iron contributes to GDM pathogenesis

Lifestyle intervention for the prevention of type 2 diabetes in women with prior gestational diabetes: A systematic review and meta‐analysis

2026-11-13T10:20:05.638Z

Meta-analysis · Diabetes Obes Metab, 2023. Incident T2D — Lifestyle intervention vs Standard care: RR 0.76 (95% CI 0.63-0.93); reduction of 24%

Mendelian randomization identifies age at menarche as an independent causal effect factor for gestational diabetes mellitus

2026-11-13T10:20:05.638Z

Research article · Diabetes Obes Metab, 2022. GDM risk per genetically predicted AAM: Genetically predicted early AAM causally associated with higher GDM risk: OR (95% CI), p 0.798 (0.649-0.980), p = .031

Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study

2026-11-13T10:16:47.554Z

Secondary analysis · Diabetologia, 2023. Fetuses with at least one malformation: Pump 13.5% · MDI 11.2%

Risk of kidney disease following a pregnancy complicated by diabetes: a longitudinal, population-based data-linkage study among Aboriginal women in the Northern Territory, Australia

2026-11-13T10:16:47.554Z

Cohort study · Diabetologia, 2023. CKD: GDM 9.2% · No diabetes 2.2% · Pre-existing diabetes 29.1%

Gestational Glucose Intolerance and Risk of Future Diabetes

2026-11-13T10:12:25.062Z

Cohort study · Diabetes Care, 2022. Incident diabetes, median 8.4 years — GGI vs Normal glucose tolerance: aHR 2.01 (95% CI 1.54-2.62); P < 0.001

Roux-en-Y Gastric Bypass Increases Glycemic Excursions During Pregnancy and Postpartum: A Prospective Cohort Study

2026-11-13T10:12:25.062Z

Cohort study · Diabetes Care, 2022. TIR, throughout pregnancy and postpartum: RYGB 87.3-89.5% · Control 93.3-96.1%

Treatment of Gestational Diabetes Mellitus and Maternal Risk of Diabetes After Pregnancy

2026-11-13T10:12:25.062Z

Cohort study · Diabetes Care, 2023. Prevalence of prediabetes/diabetes, 12 months postpartum: Prediabetes/diabetes at 12 months, groups 1-5 respectively (stepwise increase; P < 0.0001) 2.8%, 9.6%, 13.5%, 21.5%, and 32.6%

Association of Early Pregnancy Free and Total Triiodothyronine With the Subsequent Risk of Gestational Diabetes Mellitus

2026-11-13T10:04:31.875Z

Cohort study · Endocr Pract, 2022. FT3 (continuous): aOR 1.59 (95% CI 1.50-1.68)

Maternal fasting glucose levels throughout the pregnancy and risk of adverse birth outcomes in newborns: a birth cohort study in Foshan city, Southern China

2026-11-13T09:58:18.729Z

Cohort study · Eur J Endocrinol, 2023. Adverse birth outcomes per 1 mmol/L increase in maternal FPG: CHD per 1 mmol/L FPG increase in trimester 1: OR 1.14 (95% CI 1.02, 1.26)

Low Gestational Weight Gain in Women With Gestational Diabetes Is Safe With Better Metabolic Profile Postpartum

2026-11-13T09:55:31.327Z

Cohort study · J Clin Endocrinol Metab, 2022. GDM low GWG vs GDM GWG within range; P < .022; Overweight or obese postpartum: 35.7% [30] vs 56.5% [26]; less often with low GWG

Utility of In Vivo Magnetic Resonance Imaging Is Predictive of Gestational Diabetes Mellitus During Early Pregnancy

2026-11-13T09:55:31.327Z

Cohort study · J Clin Endocrinol Metab, 2022. Prediction of GDM: combined visceral fat area ratio (VFAR), placental volume and perfusion: AUC at 14 to 16 weeks 0.83

Glucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population-based cohort study

2026-11-13T09:54:14.154Z

Cohort study · Lancet Diabetes Endocrinol, 2023. Incident T2D: Gestational normoglycaemia 2.6 per 10 000 person-years (CI 2.4-2.9) · Abnormal GCT, normal OGTT 8.9 per 10 000 person-years (CI 7.4-10.6) · One abnormal OGTT value 26.1 per 10 000 person-years (CI 22.4-30.1) · GDM 71.9 per 10 000 person-years (CI 66.0-78.3)

Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial

2026-11-13T09:54:14.154Z

Randomized controlled trial · Lancet Diabetes Endocrinol, 2023. Last planned HbA1c before delivery: Degludec mean 6.2 (SE 0.07%) % · Detemir mean 6.3 (SE 0.07%) %

Novel Metabolic Subtypes in Pregnant Women and Risk of Early Childhood Obesity in Offspring

2026-11-13T05:29:11.680Z

Cohort study · JAMA Netw Open, 2023. Offspring FM% in childhood, approximately 5 years — IR-hyperglycemic vs Reference: difference 4.27 % (95% CI 1.94-6.59); greater FM% with IR-hyperglycemic

Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy

2026-11-13T05:26:49.632Z

Randomized controlled trial · N Engl J Med, 2023. Composite adverse neonatal outcome: Immediate treatment 94 (24.9%) · Control 113 (30.5%)

Prepregnancy BMI, gestational weight gain, and susceptibility to autism‐related traits: the EARLI and HOME studies

2026-11-13T05:21:31.812Z

Cohort study · Obesity (Silver Spring), 2023. Association of GWG z scores with SRS scores: HOME, mothers with prepregnancy overweight or obesity: GWG z scores positively associated with SRS scores in children with more ASD-related traits (higher SRS scores), but not in children with fewer ASD-related traits

Comparison of Accuracy of Freestyle Libre Pro and Medtronic iPro2 Continuous Glucose Monitoring Systems in Pregnancy

2026-11-13T05:18:10.408Z

Cohort study · Diabetes Technol Ther, 2023. Overall mean absolute relative difference (MARD) vs reference: iPro2 mean 8.0% ± 9.2% · FSL-Pro mean 19.0% ± 12.7%

Association of the CDKAL1 gene polymorphism with gestational diabetes mellitus in Chinese women

2026-11-13T05:16:46.983Z

Case-control study · BMJ Open Diabetes Res Care, 2023. GDM risk by CDKAL1 genotype — rs10440833 AA vs rs10440833 TT: OR 1.631 (95% CI 1.192 to 2.232)

Development and validation of a multivariable genotype-informed gestational diabetes prediction algorithm for clinical use in the Mexican population: insights into susceptibility mechanisms

2026-11-13T05:16:46.983Z

Diagnostic or prognostic study · BMJ Open Diabetes Res Care, 2023. GDM prediction model (11 SNPs + 4 clinical variables) performance: HMPMPS: AUC (further validation) 0.8001

Effect of the interaction between advanced maternal age and pre-pregnancy BMI on pre-eclampsia and GDM in Central China

2026-11-13T05:16:46.983Z

Cohort study · BMJ Open Diabetes Res Care, 2023. Pre-eclampsia, cases 788 (2.31%)

Non-efficacy of early intervention strategy for non-obese patients with early-onset gestational diabetes mellitus: solely based on the short-term outcomes

2026-11-13T05:16:46.983Z

Cohort study · BMJ Open Diabetes Res Care, 2023. large for gestational age (LGA): Treatment from early pregnancy 8.8% · Treatment from mid-pregnancy 10%

Pre-gestational diabetes and the risk of congenital heart defects in the offspring: A French nationwide study

2026-11-13T05:16:25.392Z

Cohort study · Diabetes Metab, 2023. Congenital heart defects: No-diabetes 0.8% · T1D 3.0% · T2D 2.7%

Treatment of women with mild gestational diabetes mellitus decreases the risk of adverse perinatal outcomes

2026-11-13T05:16:25.392Z

Cohort study · Diabetes Metab, 2023. Adverse maternal and neonatal outcomes — Untreated vs Treated: aOR 6.02; P = 0.002; gestational hypertension

Association between one abnormal value on 3-hour oral glucose tolerance test and adverse perinatal outcomes in twin gestation

2026-11-13T05:13:07.965Z

Cohort study · Diabetes Res Clin Pract, 2023. Adverse perinatal outcomes, one abnormal value vs normal screen: Higher rates of preterm delivery < 32 weeks, LGA neonates and composite neonatal morbidity of at least one fetus with one abnormal value vs normal screen (adjusted analyses)